Matching chelators to radiometals for radiopharmaceuticals
Radiometals comprise many useful radioactive isotopes of various metallic elements. When
properly harnessed, these have valuable emission properties that can be used for …
properly harnessed, these have valuable emission properties that can be used for …
Nanomaterial-based contrast agents
Medical imaging, which empowers the detection of physiological and pathological
processes within living subjects, has a vital role in both preclinical and clinical diagnostics …
processes within living subjects, has a vital role in both preclinical and clinical diagnostics …
Iron Oxide Decorated MoS2 Nanosheets with Double PEGylation for Chelator-Free Radiolabeling and Multimodal Imaging Guided Photothermal Therapy
Theranostics for in vivo cancer diagnosis and treatment generally requires well-designed
nanoscale platforms with multiple integrated functionalities. In this study, we uncover that …
nanoscale platforms with multiple integrated functionalities. In this study, we uncover that …
[HTML][HTML] High-resolution PET imaging with therapeutic antibody-based PD-1/PD-L1 checkpoint tracers
M Hettich, F Braun, MD Bartholomä, R Schirmbeck… - Theranostics, 2016 - ncbi.nlm.nih.gov
Checkpoint-blocking antibodies like those targeting the PD-1/PD-L1 pathway have
revolutionized oncology. We developed radiotracers based on therapeutic checkpoint …
revolutionized oncology. We developed radiotracers based on therapeutic checkpoint …
Comparison of the superagonist complex, ALT-803, to IL15 as cancer immunotherapeutics in animal models
PR Rhode, JO Egan, W Xu, H Hong, GM Webb… - Cancer immunology …, 2016 - AACR
IL15, a potent stimulant of CD8+ T cells and natural killer (NK) cells, is a promising cancer
immunotherapeutic. ALT-803 is a complex of an IL15 superagonist mutant and a dimeric …
immunotherapeutic. ALT-803 is a complex of an IL15 superagonist mutant and a dimeric …
In Vivo Targeting and Imaging of Tumor Vasculature with Radiolabeled, Antibody-Conjugated Nanographene
Herein we demonstrate that nanographene can be specifically directed to the tumor
neovasculature in vivo through targeting of CD105 (ie, endoglin), a vascular marker for …
neovasculature in vivo through targeting of CD105 (ie, endoglin), a vascular marker for …
Noninvasive imaging of immune responses
M Rashidian, EJ Keliher, AM Bilate… - Proceedings of the …, 2015 - National Acad Sciences
At their margins, tumors often contain neutrophils, dendritic cells, and activated
macrophages, which express class II MHC and CD11b products. The interplay between …
macrophages, which express class II MHC and CD11b products. The interplay between …
The ubiquitous DOTA and its derivatives: the impact of 1, 4, 7, 10-tetraazacyclododecane-1, 4, 7, 10-tetraacetic acid on biomedical imaging
GJ Stasiuk, NJ Long - Chemical Communications, 2013 - pubs.rsc.org
Over the last twenty-five years 1, 4, 7, 10-tetraazacyclododecane-1, 4, 7, 10-tetraacetic acid
(DOTA) has made a significant impact on the field of diagnostic imaging. DOTA is not the …
(DOTA) has made a significant impact on the field of diagnostic imaging. DOTA is not the …
Antibody fragment and affibody immunoPET imaging agents: radiolabelling strategies and applications
R Fu, L Carroll, G Yahioglu, EO Aboagye… - …, 2018 - Wiley Online Library
Antibodies have long been recognised as potent vectors for carrying diagnostic medical
radionuclides, contrast agents and optical probes to diseased tissue for imaging. The area of …
radionuclides, contrast agents and optical probes to diseased tissue for imaging. The area of …
[HTML][HTML] The chemical scaffold of theranostic radiopharmaceuticals: radionuclide, bifunctional chelator, and pharmacokinetics modifying linker
Therapeutic radiopharmaceuticals have been researched extensively in the last decade as
a result of the growing research interest in personalized medicine to improve diagnostic …
a result of the growing research interest in personalized medicine to improve diagnostic …